InspireMD Inc (NYSE MKT LLC:NSPR)

0.2599
Delayed Data
As of Apr 20
 -0.0142 / -5.18%
Today’s Change
0.23
Today|||52-Week Range
3.25
-66.57%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$21.4M

Company Description

InspireMD, Inc. engages in the development and commercialization of the stent platform technology MGuard, which provides embolic protection in stenting procedures by placing a micronet mesh sleeve over a stent. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack), and saphenous vein graft coronary interventions (bypass surgery). The company was founded on February 29, 2008 and is headquartered in Boston, MA.

Contact Information

InspireMD, Inc.
321 Columbus Avenue
Boston Massachusetts 02116
P:(857) 453-6553
Investor Relations:

Employees

Shareholders

Mutual fund holders3.24%
Other institutional21.09%
Individual stakeholders14.11%

Top Executives

Alan W. MilinazzoPresident, Chief Executive Officer & Director
James J. BarryChief Operating Officer, Director & Executive VP
Craig ShoreCFO, Secretary, Treasurer & CAO
Eli BarCTO, Senior Vice President-Research & Development
Gwen K. BameVice President-Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account